Home/Filings/4/0001567619-21-014178
4//SEC Filing

Dillon Michael P. 4

Accession 0001567619-21-014178

CIK 0001676725other

Filed

Jul 28, 8:00 PM ET

Accepted

Jul 29, 5:18 PM ET

Size

13.2 KB

Accession

0001567619-21-014178

Insider Transaction Report

Form 4
Period: 2021-07-27
Dillon Michael P.
SVP, Chief Scientific Officer
Transactions
  • Sale

    Common Stock

    2021-07-27$25.15/sh10,000$251,46098,789 total
  • Exercise/Conversion

    Common Stock

    2021-07-27$4.31/sh+5,000$21,550108,789 total
  • Exercise/Conversion

    Stock Option (right to buy)

    2021-07-275,00039,500 total
    Exercise: $6.92Exp: 2030-02-20Common Stock (5,000 underlying)
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2021-07-275,00067,735 total
    Exercise: $4.31Exp: 2028-02-26Common Stock (5,000 underlying)
  • Exercise/Conversion

    Common Stock

    2021-07-27$6.92/sh+5,000$34,600103,789 total
Footnotes (4)
  • [F1]The transactions reported herein were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan.
  • [F2]This transaction was executed in multiple trades in prices ranging from $24.95 to $25.28, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
  • [F3]25% of the shares subject to the option vest on the first anniversary measured from January 1, 2020 (the "Vesting Commencement Date"), and 1/48th of the total number of shares vest monthly thereafter, such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date.
  • [F4]25% of the shares subject to the option vest on the first anniversary measured from February 27, 2018 (the "Vesting Commencement Date"), and 1/48th of the total number of shares vest monthly thereafter, such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date.

Documents

1 file

Issuer

IDEAYA Biosciences, Inc.

CIK 0001676725

Entity typeother

Related Parties

1
  • filerCIK 0001777415

Filing Metadata

Form type
4
Filed
Jul 28, 8:00 PM ET
Accepted
Jul 29, 5:18 PM ET
Size
13.2 KB